Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

× No keyword cloud information.

40 in total

1. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.

Authors: Dhruba J Bharali; Ilona Klejbor; Ewa K Stachowiak; Purnendu Dutta; Indrajit Roy; Navjot Kaur; Earl J Bergey; Paras N Prasad; Michal K Stachowiak
Journal: Proc Natl Acad Sci U S A Date: 2005-07-28 Impact factor: 11.205

Review 2. Mechanism of multidrug resistance in relation to passive membrane permeation.

Authors: Gera D Eytan
Journal: Biomed Pharmacother Date: 2005-04 Impact factor: 6.529

3. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.

Authors: T Minko; P Kopecková; J Kopecek
Journal: Pharm Res Date: 1999-07 Impact factor: 4.200

Review 4. Diagnostics of multidrug resistance in cancer.

Authors: G Szakács; K Jakab; F Antal; B Sarkadi
Journal: Pathol Oncol Res Date: 1998 Impact factor: 3.201

Review 5. Glutathione and related enzymes in multidrug resistance.

Authors: M L O'Brien; K D Tew
Journal: Eur J Cancer Date: 1996-06 Impact factor: 9.162

6. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.

Authors: Javier A Menendez; Luciano Vellon; Ramon Colomer; Ruth Lupu
Journal: Int J Cancer Date: 2005-05-20 Impact factor: 7.396

7. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.

Authors: S Bennis; C Chapey; P Couvreur; J Robert
Journal: Eur J Cancer Date: 1994 Impact factor: 9.162

8. pH-Responsive copolymer assemblies for controlled release of doxorubicin.

Authors: Elizabeth R Gillies; Jean M J Fréchet
Journal: Bioconjug Chem Date: 2005 Mar-Apr Impact factor: 4.774

9. Enhanced sensitivity of human hepatoma cells to 5-fluorouracil by small interfering RNA targeting Bcl-2.

Authors: Tatsuo Kanda; Osamu Yokosuka; Fumio Imazeki; Makoto Arai; Hiromitsu Saisho
Journal: DNA Cell Biol Date: 2005-12 Impact factor: 3.311

10. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.

Authors: Junichi Yano; Kazuko Hirabayashi; Shin-Ichiro Nakagawa; Tohru Yamaguchi; Masaki Nogawa; Isao Kashimori; Haruna Naito; Hidetoshi Kitagawa; Kouichi Ishiyama; Tadaaki Ohgi; Tatsuro Irimura
Journal: Clin Cancer Res Date: 2004-11-15 Impact factor: 12.531

121 in total

1. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.

Authors: Shanta Raj Bhattarai; Elayaraja Muthuswamy; Amit Wani; Michal Brichacek; Antonio L Castañeda; Stephanie L Brock; David Oupicky
Journal: Pharm Res Date: 2010-08-21 Impact factor: 4.200

2. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.

Authors: Huan Meng; Monty Liong; Tian Xia; Zongxi Li; Zhaoxia Ji; Jeffrey I Zink; Andre E Nel
Journal: ACS Nano Date: 2010-08-24 Impact factor: 15.881

3. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization.

Authors: Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal: Pharm Res Date: 2013-12-03 Impact factor: 4.200

4. Polyethylenimine-cyclodextrin-tegafur conjugate shows anti-cancer activity and a potential for gene delivery.

Authors: Qi-da Hu; Hui Fan; Wei-jian Lou; Qing-qing Wang; Gu-ping Tang
Journal: J Zhejiang Univ Sci B Date: 2011-09 Impact factor: 3.066

Review 5. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors: Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal: Mol Diagn Ther Date: 2018-10 Impact factor: 4.074

6. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.

Authors: Jiayi Pan; Livia P Mendes; Momei Yao; Nina Filipczak; Sumanta Garai; Ganesh A Thakur; Can Sarisozen; Vladimir P Torchilin
Journal: Eur J Pharm Biopharm Date: 2019-01-08 Impact factor: 5.571

7. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.

Authors: Xiaojing Zhao; Qi Chen; Wei Liu; Yusang Li; Hebin Tang; Xuhan Liu; Xiangliang Yang
Journal: Int J Nanomedicine Date: 2014-12-30

8. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.

Authors: Lin Zhu; Federico Perche; Tao Wang; Vladimir P Torchilin
Journal: Biomaterials Date: 2014-02-13 Impact factor: 12.479

9. Materials innovation for co-delivery of diverse therapeutic cargos.

Authors: Megan E Godsey; Smruthi Suryaprakash; Kam W Leong
Journal: RSC Adv Date: 2013-12-21 Impact factor: 3.361

10. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.

Authors: Yuling Xiao; Renata Jaskula-Sztul; Alireza Javadi; Wenjin Xu; Jacob Eide; Ajitha Dammalapati; Muthusamy Kunnimalaiyaan; Herbert Chen; Shaoqin Gong
Journal: Nanoscale Date: 2012-11-21 Impact factor: 7.790